Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
373.5 GBX | +2.33% | +8.58% | +6.56% |
03-25 | Chemring Director Ord sells GBP500,000 in shares | AN |
03-18 | Stocks downbeat before central bank rate storm | AN |
Valuation
Fiscal Period: Ottobre | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 562.9 | 734.3 | 826.5 | 855.2 | 781.2 | 1,017 | - | - |
Enterprise Value (EV) 1 | 638.6 | 782.5 | 853.1 | 862.4 | 795.6 | 1,084 | 1,090 | 1,079 |
P/E ratio | 26.1 x | 21.7 x | 20.3 x | 17.9 x | 21.3 x | 19.3 x | 17.4 x | 15.9 x |
Yield | 1.79% | 1.5% | 1.64% | 1.89% | 2.47% | 2.12% | 2.35% | 2.61% |
Capitalization / Revenue | 1.49 x | 1.82 x | 2.1 x | 1.93 x | 1.65 x | 2 x | 1.86 x | 1.7 x |
EV / Revenue | 1.69 x | 1.94 x | 2.17 x | 1.95 x | 1.68 x | 2.14 x | 1.99 x | 1.8 x |
EV / EBITDA | 10.4 x | 10.5 x | 11.2 x | 10.5 x | 8.99 x | 11.3 x | 10.5 x | 9.48 x |
EV / FCF | 37.3 x | 22.3 x | 18.8 x | 20.3 x | 25.1 x | 110 x | 35.5 x | 23.1 x |
FCF Yield | 2.68% | 4.49% | 5.33% | 4.93% | 3.98% | 0.91% | 2.82% | 4.34% |
Price to Book | 1.76 x | 2.4 x | 2.39 x | 2.08 x | 2.13 x | 2.7 x | 2.39 x | 2.14 x |
Nbr of stocks (in thousands) | 280,052 | 281,893 | 282,580 | 283,180 | 279,515 | 272,329 | - | - |
Reference price 2 | 2.010 | 2.605 | 2.925 | 3.020 | 2.795 | 3.735 | 3.735 | 3.735 |
Announcement Date | 16/12/19 | 15/12/20 | 14/12/21 | 13/12/22 | 12/12/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: October | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 378.6 | 402.5 | 393.3 | 442.8 | 472.6 | 507.8 | 547.7 | 598.2 |
EBITDA 1 | 61.2 | 74.6 | 76.4 | 82.3 | 88.5 | 95.55 | 104.3 | 113.9 |
EBIT 1 | 44 | 54.7 | 57.5 | 64 | 69.2 | 73.2 | 80.22 | 88.98 |
Operating Margin | 11.62% | 13.59% | 14.62% | 14.45% | 14.64% | 14.42% | 14.65% | 14.87% |
Earnings before Tax (EBT) 1 | 26.7 | 43.3 | 48.8 | 51.8 | 44.1 | 67.15 | 74.15 | 82.18 |
Net income 1 | 21.9 | 34.7 | 41.5 | 47.4 | 37.7 | 53.98 | 59 | 65.35 |
Net margin | 5.78% | 8.62% | 10.55% | 10.7% | 7.98% | 10.63% | 10.77% | 10.92% |
EPS 2 | 0.0770 | 0.1200 | 0.1440 | 0.1690 | 0.1310 | 0.1932 | 0.2150 | 0.2356 |
Free Cash Flow 1 | 17.1 | 35.1 | 45.5 | 42.5 | 31.7 | 9.875 | 30.72 | 46.8 |
FCF margin | 4.52% | 8.72% | 11.57% | 9.6% | 6.71% | 1.94% | 5.61% | 7.82% |
FCF Conversion (EBITDA) | 27.94% | 47.05% | 59.55% | 51.64% | 35.82% | 10.33% | 29.45% | 41.09% |
FCF Conversion (Net income) | 78.08% | 101.15% | 109.64% | 89.66% | 84.08% | 18.3% | 52.07% | 71.61% |
Dividend per Share 2 | 0.0360 | 0.0390 | 0.0480 | 0.0570 | 0.0690 | 0.0791 | 0.0877 | 0.0974 |
Announcement Date | 16/12/19 | 15/12/20 | 14/12/21 | 13/12/22 | 12/12/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: Ottobre | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S2 | 2024 S1 | 2024 S2 |
---|---|---|---|---|---|---|---|---|---|
Net sales | 191 | 211.5 | 198.5 | 194.8 | 220.4 | 222.4 | - | - | - |
EBITDA | - | 39.4 | 37.6 | 38.8 | 42.8 | 39.5 | - | - | - |
EBIT | - | 29.1 | - | 29.4 | 33.5 | 30.5 | 42.6 | - | 50.5 |
Operating Margin | - | 13.76% | - | 15.09% | 15.2% | 13.71% | - | - | - |
Earnings before Tax (EBT) | - | - | 24.3 | 24.5 | 28.9 | 22.9 | 22.1 | - | 47.5 |
Net income | - | - | 21.4 | 20.1 | 26.5 | 20.9 | 19 | - | 38 |
Net margin | - | - | 10.78% | 10.32% | 12.02% | 9.4% | - | - | - |
EPS 1 | 0.0690 | - | 0.0740 | 0.0700 | 0.0920 | 0.0740 | 0.0650 | 0.0540 | 0.1360 |
Dividend per Share 1 | - | - | 0.0160 | 0.0320 | 0.0190 | 0.0380 | 0.0460 | 0.0270 | 0.0530 |
Announcement Date | 03/06/20 | 15/12/20 | 03/06/21 | 14/12/21 | 08/06/22 | 13/12/22 | 12/12/23 | - | - |
Balance Sheet Analysis
Fiscal Period: Ottobre | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 75.7 | 48.2 | 26.6 | 7.2 | 14.4 | 67.1 | 72.8 | 62.3 |
Net Cash position 1 | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 1.237 x | 0.6461 x | 0.3482 x | 0.0875 x | 0.1627 x | 0.7023 x | 0.6982 x | 0.5471 x |
Free Cash Flow 1 | 17.1 | 35.1 | 45.5 | 42.5 | 31.7 | 9.88 | 30.7 | 46.8 |
ROE (net income / shareholders' equity) | 11.4% | 8.18% | 14% | 14.7% | 14.3% | 14.8% | 14.7% | 14.4% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share 2 | 1.150 | 1.090 | 1.220 | 1.450 | 1.310 | 1.380 | 1.560 | 1.740 |
Cash Flow per Share 2 | 0.2200 | 0.2600 | 0.2600 | 0.2800 | - | -0.1900 | -0.0400 | 0.0200 |
Capex 1 | 44.8 | 40.8 | 30.2 | 34.5 | 34.2 | 71.2 | 54.4 | 45.9 |
Capex / Sales | 11.83% | 10.14% | 7.68% | 7.79% | 7.24% | 14.02% | 9.94% | 7.68% |
Announcement Date | 16/12/19 | 15/12/20 | 14/12/21 | 13/12/22 | 12/12/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.56% | 1.27B | |
+20.53% | 135B | |
+9.53% | 77.91B | |
+2.63% | 71.1B | |
+20.67% | 50.29B | |
+40.51% | 43.87B | |
+1.86% | 40.78B | |
+42.10% | 31.95B | |
+82.72% | 24.31B | |
+19.32% | 23.26B |
- Stock Market
- Equities
- CHG Stock
- Financials Chemring Group PLC